ATE244239T1 - Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln - Google Patents

Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln

Info

Publication number
ATE244239T1
ATE244239T1 AT00925528T AT00925528T ATE244239T1 AT E244239 T1 ATE244239 T1 AT E244239T1 AT 00925528 T AT00925528 T AT 00925528T AT 00925528 T AT00925528 T AT 00925528T AT E244239 T1 ATE244239 T1 AT E244239T1
Authority
AT
Austria
Prior art keywords
octan
polymorphs
products containing
containing same
medicinal products
Prior art date
Application number
AT00925528T
Other languages
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE244239T1 publication Critical patent/ATE244239T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00925528T 1999-06-01 2000-05-18 Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln ATE244239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE244239T1 true ATE244239T1 (de) 2003-07-15

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00925528T ATE244239T1 (de) 1999-06-01 2000-05-18 Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln

Country Status (48)

Country Link
US (1) US6255320B1 (de)
EP (1) EP1181290B1 (de)
JP (1) JP3830816B2 (de)
KR (1) KR100476606B1 (de)
CN (1) CN1146565C (de)
AP (1) AP2001002349A0 (de)
AR (1) AR033331A1 (de)
AT (1) ATE244239T1 (de)
AU (1) AU767334B2 (de)
BG (1) BG65240B1 (de)
BR (1) BR0011094A (de)
CA (1) CA2372238C (de)
CO (1) CO5170463A1 (de)
CY (1) CY2007011I1 (de)
CZ (1) CZ295819B6 (de)
DE (1) DE60003679T2 (de)
DK (1) DK1181290T3 (de)
DZ (1) DZ3050A1 (de)
EA (1) EA003731B1 (de)
EC (1) ECSP003508A (de)
EE (1) EE200100656A (de)
ES (1) ES2199825T3 (de)
GT (1) GT200000087A (de)
HN (1) HN2000000077A (de)
HR (1) HRP20010904A2 (de)
HU (1) HUP0201301A3 (de)
IL (1) IL146406A0 (de)
MA (1) MA26742A1 (de)
MX (1) MXPA01012325A (de)
MY (1) MY133508A (de)
NO (1) NO20015848L (de)
NZ (1) NZ515349A (de)
OA (1) OA11956A (de)
PA (1) PA8496101A1 (de)
PE (1) PE20010209A1 (de)
PL (1) PL196046B1 (de)
PT (1) PT1181290E (de)
SI (1) SI1181290T1 (de)
SK (1) SK285820B6 (de)
SV (1) SV2001000093A (de)
TN (1) TNSN00120A1 (de)
TR (1) TR200103473T2 (de)
TW (1) TWI285204B (de)
UA (1) UA66925C2 (de)
UY (1) UY26176A1 (de)
WO (1) WO2000073304A1 (de)
YU (1) YU81101A (de)
ZA (1) ZA200109775B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0507301A (pt) * 2004-01-30 2007-06-26 Pfizer Prod Inc composições farmacêuticas de antagonistas do receptor de nuerocinina e ciclodextrina e métodos para melhor toleráncia no local de injeção
MXPA06007964A (es) * 2004-01-30 2007-01-26 Pfizer Prod Inc Antagonistas del receptor nk-1 para mejorar la recuperacion de anestesia.
JP5021318B2 (ja) * 2004-01-30 2012-09-05 ファイザー・プロダクツ・インク β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤
KR100812046B1 (ko) * 2004-02-02 2008-03-10 화이자 프로덕츠 인크. 1-(2s,3s)-2-벤즈히드릴-n-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법
SG11201507286QA (en) * 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27776C2 (uk) * 1991-05-31 2000-10-16 Пфайзер Інк. Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PL196046B1 (pl) 2007-11-30
EP1181290B1 (de) 2003-07-02
JP2003501354A (ja) 2003-01-14
IL146406A0 (en) 2002-07-25
CZ20014269A3 (cs) 2002-04-17
TWI285204B (en) 2007-08-11
DE60003679T2 (de) 2004-05-27
EA200101108A1 (ru) 2002-04-25
BR0011094A (pt) 2002-03-19
CY2007011I2 (el) 2010-07-28
DZ3050A1 (fr) 2004-03-27
PA8496101A1 (es) 2002-07-30
SK17332001A3 (sk) 2002-07-02
HUP0201301A3 (en) 2002-10-28
UY26176A1 (es) 2000-12-29
HK1046284A1 (en) 2003-01-03
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
DE60003679D1 (de) 2003-08-07
CN1146565C (zh) 2004-04-21
AU767334B2 (en) 2003-11-06
SK285820B6 (sk) 2007-09-06
EE200100656A (et) 2003-02-17
ES2199825T3 (es) 2004-03-01
WO2000073304A1 (en) 2000-12-07
SV2001000093A (es) 2001-11-08
PT1181290E (pt) 2003-09-30
AR033331A1 (es) 2003-12-17
CN1353711A (zh) 2002-06-12
OA11956A (en) 2006-04-13
NO20015848D0 (no) 2001-11-30
DK1181290T3 (da) 2003-09-29
ECSP003508A (es) 2002-02-25
TR200103473T2 (tr) 2002-04-22
MY133508A (en) 2007-11-30
KR20020010688A (ko) 2002-02-04
CA2372238C (en) 2006-12-19
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
HUP0201301A2 (en) 2002-08-28
NZ515349A (en) 2004-03-26
YU81101A (sh) 2004-07-15
HN2000000077A (es) 2001-02-02
KR100476606B1 (ko) 2005-03-18
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
BG106204A (en) 2002-07-31
PL352716A1 (en) 2003-09-08
JP3830816B2 (ja) 2006-10-11
TNSN00120A1 (fr) 2005-11-10
MXPA01012325A (es) 2002-07-22
MA26742A1 (fr) 2004-12-20
AU4424800A (en) 2000-12-18
SI1181290T1 (en) 2003-12-31
GT200000087A (es) 2001-11-22
EP1181290A1 (de) 2002-02-27
UA66925C2 (uk) 2004-06-15
AP2001002349A0 (en) 2001-12-31
PE20010209A1 (es) 2001-03-01
EA003731B1 (ru) 2003-08-28
BG65240B1 (bg) 2007-09-28
ZA200109775B (en) 2002-11-28
CO5170463A1 (es) 2002-06-27

Similar Documents

Publication Publication Date Title
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
HUP0204515A3 (en) 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
PL352985A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
HUP0303524A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0200309A3 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0204085A3 (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL150981A0 (en) Kahalalide derivatives and pharmaceutical compositions containing the same
GB0029936D0 (en) A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE244239T1 (de) Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln
HUP0200343A3 (en) Phenylalaninol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0102609A3 (en) N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar
PL345309A1 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
IL148164A0 (en) Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
HUP9803041A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0202929A3 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1181290

Country of ref document: EP

REN Ceased due to non-payment of the annual fee